- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01306500
Effect of Gastric Lavage in Preventing Feeding Problems in Babies Born With Meconium Stained Amniotic Fluid (GLAM)
Effect of Gastric Lavage in Preventing Feeding Problems in Late Preterm and Term Neonates Born With Meconium Stained Amniotic Fluid : A Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Meconium passage in newborn infants is a developmentally programmed event normally occurring within first 24-48 hours of birth. The meconium staining of amniotic fluid occurs in 12% of all live births per annuum.
The routine use of gastric lavage in MSAF babies has been advocated for a long time as a part of the conventional treatment. Meconium in stomach is hypothesized to act as an irritant and cause vomiting and retching. Surprisingly this recommendation is also made in some textbooks without supporting evidence.
Orogastric tube insertion and subsequent gastric lavage can cause complications like bradycardia, apnea, vomiting, trauma, aspiration and esophageal or gastric perforations. Some researchers have found that gastric suction done at birth is associated with long term risk for functional intestinal disorder. The sequence of prefeeding behaviour is disrupted in children who undergo gastric suction and it can delay initiation of breast feeding. Small elevation in mean arterial blood pressure, increased retching have also been reported The role of gastric lavage in preventing feeding problems and secondary meconium aspiration syndrome has not been systematically evaluated. If this procedure is not proven to be beneficial it will prevent potential complications which may arise due to it in a significant number of babies. Also in a resource limited country the cost of materials required and time of medical personnel will be saved. Hence the purpose of this prospective randomized controlled trial is to compare the incidence of feeding problems and secondary meconium aspiration syndrome, in gastric lavage group vs no lavage group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110001
- Kalawati Saran children's Hospital, Lady Hardinge Medical College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Gestation > 34 weeks
- Meconium staining of amniotic fluid
- Vigorous babies
Exclusion Criteria:
- Major Congenital malformation
- Non vigorous babies
- Refusal of consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Gastric lavage Group
In neonates randomized to intervention Group (gastric lavage group) gastric lavage was done in the labor room after initial stabilization
|
8 Fr feeding tube was inserted orally with length equal to distance from the bridge of the nose to the earlobe and from the earlobe to a point halfway between the xiphoid process and the umbilicus.
20ml normal saline was used for gastric lavage.
It was ensured that entire amount of normal saline used was removed from stomach.
|
No Intervention: No gastric lavage
Neonates randomized to 'No gastric lavage group' will receive supportive treatment as per standard unit protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feeding problems
Time Frame: Till discharge from hospital
|
Feeding problems were considered to be present
|
Till discharge from hospital
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary meconium aspiration syndrome
Time Frame: Till discharge from hospital
|
Presence of tachypnea or respiratory distress in a previously well baby following vomiting.
|
Till discharge from hospital
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sushma Nangia, MBBS, MD, DM, Lady Hardinge Medical College, New Delhi, India
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LHMC/035/2010/GLAM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastritis of Newborn
-
Beijing University of Chinese MedicineHarvard Medical School (HMS and HSDM); China Academy of Chinese Medical Sciences and other collaboratorsRecruitingRisk Assessment of Chronic Atrophic Gastritis Malignant TransformationChina
-
Beijing University of Chinese MedicineHarvard Medical School (HMS and HSDM); China Academy of Chinese Medical Sciences and other collaboratorsUnknownTCM Syndrome of Chronic Atrophic GastritisChina
-
New York Presbyterian HospitalUnknownGastric Cancer | Gastric Dysplasia | Intestinal Metaplasia of Gastric Mucosa | Atrophic Gastritis
-
Stanford UniversityRecruitingGastric Cancer | Helicobacter Pylori Infection | Intestinal Metaplasia of Gastric Mucosa | Atrophic GastritisUnited States
-
Daewoong Pharmaceutical Co. LTD.CompletedAcute Gastritis | Chronic GastritisKorea, Republic of
-
Addpharma Inc.CompletedAcute Gastritis | Chronic GastritisKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedAcute Gastritis | Chronic GastritisKorea, Republic of
-
Dong-A ST Co., Ltd.UnknownAcute Gastritis | Chronic GastritisKorea, Republic of
-
Instituto Ecuatoriano de Enfermedades DigestivasCompletedGastritis | Atrophic Gastritis | Helicobacter Pylori Associated GastritisEcuador
-
Dong-A ST Co., Ltd.RecruitingGastritis Acute | Gastritis ChronicKorea, Republic of
Clinical Trials on Gastric lavage
-
Sherief Abd-ElsalamRecruiting
-
Tanta UniversityCompletedAluminum Phosphide PoisoningEgypt
-
Assistance Publique - Hôpitaux de ParisCompletedUpper Gastrointestinal BleedingFrance
-
US Department of Veterans AffairsCompleted
-
Kinamed IncorporatedUS Department of Veterans AffairsCompletedPostoperative Complications | Memory DisordersUnited States
-
Sheba Medical CenterRabin Medical Center; Meir Medical Center; Shaare Zedek Medical CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Serous Cystadenocarcinoma | Primary Peritoneal CarcinomaIsrael
-
Prelife KftCompletedInfertility, Female | IVF
-
Universitätsmedizin MannheimHeidelberg UniversityTerminatedAdenocarcinoma | Stomach NeoplasmsGermany
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPancreatic Fistula | Pancreaticoduodenal; FistulaChina
-
United States Naval Medical Center, San DiegoNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsNot yet recruitingTibial Fractures | Post-traumatic; Arthrosis | Post-Traumatic Osteoarthritis of Ankle